BioHealth News Archive
Financing Trends for Q1 2020
The COVID-19 pandemic has caused— and will continue to cause—much uncertainty in the worldwide financial markets. We expect to see substantial declines in the…
Read MoreBIO – News Update (May 14, 2020)
We are living and working through a period in human history when scientific leadership and knowledge are crucial for our nation, our organization and…
Read MoreMaryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO · BioBuzz
Immunomic Therapeutics Incorporated (ITI), located in Rockville, Maryland recently announced it had closed on $61.3M in financing, exceeding its initial fundraising projections by over…
Read MoreNet Health Acquires Tissue Analytics
PITTSBURGH, May 14, 2020 /PRNewswire/ -- Net Health, a premier provider of cloud-based Electronic Health Record (EHR) software for specialized care settings, today announced…
Read MoreBiotech’s new top lobbyist is a social justice advocate.
WASHINGTON — Michelle McMurry-Heath doesn’t talk about biotech the way her peers do. Where other executives and experts might bring up “access,” and “reimbursement,”…
Read MoreIt’s Moncef Slaoui. Trump administration settles on ex-GSK vaccines chief as Covid-19 R&D czar — reports – Endpoints News
The Trump administration has chosen their drug and vaccine development czar to head up the R&D side of the Covid-19 attack plan, but it’s…
Read MoreCenter for Innovative Technology campus sells for $47.35M | Virginia Business
The Center for Innovative Technology (CIT) office building complex in Herndon has sold for $47.35 million, Gov. Ralph Northam announced Thursday. The Virginia Department…
Read MoreNIH Launches Clinical Trial to Study Hydroxychloroquine Efficacy in COVID-19
The lack of treatment options for COVID-19 patients, potential promise in repurposing drugs, and controversy surrounding the anti-malarial drug hydroxychloroquine have created a storm…
Read MoreWith $306M for serology research, NCI mobilizes labs, academic centers, grantees, contractors, and SBIR – The Cancer Letter
The NCI Board of Scientific Advisors has approved concepts for an RFA and an RFP to support research in serological testing. The plan presented…
Read MoreEntrepreneurship in Baseball – Twinkie Town
At North Dakota State this semester, I took a course titled “Economics of Entrepreneurship”. It was a deep dive into economic theory with a…
Read MoreCouncil funded grants support local businesses to pivot to PPE, emergency response – Hans Riemer, CouncilmemberHans Riemer, Councilmember
ROCKVILLE, Md., May 15, 2020—Supported by a special appropriation by the Council, the Montgomery County Economic Development Corporation (MCEDC) has awarded 25 local businesses…
Read MoreVaccine Company Novavax Gets $388 Million Grant For Coronavirus Vaccine
TOPLINE Public vaccine company Novavax announced today that it will receive up to $388 million from the Coalition for Epidemic Preparedness (CEPI) to continue…
Read MoreSilicon Valley Super Angel Dr. Faz Bashi, M.D. joins Rich Bendis Virtually for a New Episode of BioTalk
Silicon Valley Super Angel Angel Investor, Dr. Faz Bashi, M.D., joins BioTalk from the West Coast to discuss the Venture Capital, partnerships and staying…
Read MoreMaryland Biotechnology Investment Incentive Tax Credit (BIITC) Program Still on but Delayed until mid-August
As a result of the ongoing COVID-19 pandemic and the impact on both government and business operations, under the authority of executive order, the…
Read MoreFina Biosolutions Awarded $289,000 from NIAID to Develop Carrier Protein for Conjugate Vaccines
Rockville, Maryland’s Fina Biosolutions recently was awarded an SBIR grant to develop a genetically detoxified tetanus toxin as a carrier protein for conjugate vaccines. The NIAID…
Read More